Article
Ex vivo effects of low dose delayed release rapamycin on agonist-induced platelet aggregation, activation and procoagulant platelet phenotypes in domestic cats
2025-11-11
Abstract excerpt
<title>Abstract</title> <p> Cardiogenic arterial thromboembolism (CATE) is a complication of hypertrophic cardiomyopathy (HCM) with a high mortality rate. Despite anti-platelet drugs use, on-treatment recurrence rate remains high indicating a critical need to discover novel therapies. Studies in both humans and cats show that low dose delayed release rapamycin (LDDRR) can reduce the progression of left ventricul...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- acadb172-0168-5c85-a5d2-8f9a9ed4b78f
- DOI
- 10.21203/rs.3.rs-7068900/v1
